$GENB

Generate Biomedicines, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Somerville, MA

GENB chart

What traders are saying about $GENB

Latest posts

Generate Biomedicines, Inc. news

Generate Biomedicines, Inc. key financials

USD2025
Total assets (year end)$330.2M
Cash and equivalents (year end)$121.7M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • S-1S-1

About Generate Biomedicines, Inc.

Ticker
GENB (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Somerville, MA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
2100782

Frequently asked questions

What exchange is Generate Biomedicines, Inc. listed on?

Generate Biomedicines, Inc. trades on the Nasdaq under the ticker symbol GENB.

What industry is Generate Biomedicines, Inc. in?

Generate Biomedicines, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Generate Biomedicines, Inc. headquartered?

Generate Biomedicines, Inc.'s business address on file with the SEC is in Somerville, MA.

When does Generate Biomedicines, Inc.'s fiscal year end?

Generate Biomedicines, Inc.'s fiscal year ends on December 31.